Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/31/16
End: 03/31/18
Due: 03/31/19
Phase: N/A
Priority: Normal
Start: 09/30/16
End: 10/06/17
Due: 10/06/18
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer | NCT02662634 | GU Research Network, LLC | user2@example.com | None | 2016-03-31 | 2018-03-31 | 2019-03-31 | - | - | 2025-07-14 |
| Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201 | NCT02887976 | GU Research Network, LLC | user2@example.com | None | 2016-09-30 | 2017-10-06 | 2018-10-06 | - | - | 2025-07-14 |